nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—ALB—Irinotecan—colon cancer	0.0869	0.153	CbGbCtD
Nortriptyline—ALB—Fluorouracil—colon cancer	0.0834	0.147	CbGbCtD
Nortriptyline—CYP2C9—Capecitabine—colon cancer	0.0758	0.133	CbGbCtD
Nortriptyline—CYP3A5—Irinotecan—colon cancer	0.0699	0.123	CbGbCtD
Nortriptyline—CYP3A5—Vincristine—colon cancer	0.0611	0.107	CbGbCtD
Nortriptyline—CYP1A2—Fluorouracil—colon cancer	0.0499	0.0877	CbGbCtD
Nortriptyline—ALB—Methotrexate—colon cancer	0.046	0.0809	CbGbCtD
Nortriptyline—CYP2C9—Fluorouracil—colon cancer	0.045	0.079	CbGbCtD
Nortriptyline—CYP3A4—Irinotecan—colon cancer	0.0272	0.0479	CbGbCtD
Nortriptyline—CYP3A4—Vincristine—colon cancer	0.0238	0.0419	CbGbCtD
Nortriptyline—CHRM3—ureter—colon cancer	0.0229	0.136	CbGeAlD
Nortriptyline—ORM1—bile—colon cancer	0.018	0.107	CbGeAlD
Nortriptyline—CHRM3—muscle of abdomen—colon cancer	0.0165	0.0977	CbGeAlD
Nortriptyline—HTR2A—myenteric nerve plexus—colon cancer	0.0117	0.0693	CbGeAlD
Nortriptyline—HTR2A—vein—colon cancer	0.00755	0.0447	CbGeAlD
Nortriptyline—ORM1—gall bladder—colon cancer	0.005	0.0296	CbGeAlD
Nortriptyline—ALB—gall bladder—colon cancer	0.00439	0.0259	CbGeAlD
Nortriptyline—CHRM5—epithelium—colon cancer	0.00352	0.0208	CbGeAlD
Nortriptyline—ADRA1D—epithelium—colon cancer	0.00314	0.0186	CbGeAlD
Nortriptyline—ADRA1B—renal system—colon cancer	0.00298	0.0176	CbGeAlD
Nortriptyline—PTGS1—endothelium—colon cancer	0.00288	0.017	CbGeAlD
Nortriptyline—PTGS1—blood vessel—colon cancer	0.00266	0.0157	CbGeAlD
Nortriptyline—HTR2A—endothelium—colon cancer	0.0026	0.0154	CbGeAlD
Nortriptyline—HTR2A—blood vessel—colon cancer	0.0024	0.0142	CbGeAlD
Nortriptyline—CHRM3—smooth muscle tissue—colon cancer	0.00189	0.0112	CbGeAlD
Nortriptyline—Petechiae—Capecitabine—colon cancer	0.00189	0.00734	CcSEcCtD
Nortriptyline—CHRM3—renal system—colon cancer	0.00182	0.0108	CbGeAlD
Nortriptyline—HTR1A—renal system—colon cancer	0.00182	0.0107	CbGeAlD
Nortriptyline—ORM1—bone marrow—colon cancer	0.00181	0.0107	CbGeAlD
Nortriptyline—ADRA1A—epithelium—colon cancer	0.0018	0.0107	CbGeAlD
Nortriptyline—Disorientation—Fluorouracil—colon cancer	0.0018	0.00701	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Irinotecan—colon cancer	0.00172	0.00669	CcSEcCtD
Nortriptyline—Bone marrow depression—Methotrexate—colon cancer	0.00171	0.00666	CcSEcCtD
Nortriptyline—Oropharyngeal pain—Capecitabine—colon cancer	0.00171	0.00664	CcSEcCtD
Nortriptyline—SLC6A4—digestive system—colon cancer	0.00168	0.00992	CbGeAlD
Nortriptyline—Nocturia—Capecitabine—colon cancer	0.00167	0.00651	CcSEcCtD
Nortriptyline—ADRA1A—renal system—colon cancer	0.00167	0.0099	CbGeAlD
Nortriptyline—Urinary retention—Vincristine—colon cancer	0.00165	0.0064	CcSEcCtD
Nortriptyline—Ataxia—Vincristine—colon cancer	0.00163	0.00633	CcSEcCtD
Nortriptyline—Coordination abnormal—Capecitabine—colon cancer	0.00158	0.00615	CcSEcCtD
Nortriptyline—Irritability—Fluorouracil—colon cancer	0.00154	0.00599	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Irinotecan—colon cancer	0.00154	0.00598	CcSEcCtD
Nortriptyline—Ataxia—Fluorouracil—colon cancer	0.00152	0.0059	CcSEcCtD
Nortriptyline—CHRM3—digestive system—colon cancer	0.0015	0.00885	CbGeAlD
Nortriptyline—Gingivitis—Methotrexate—colon cancer	0.00147	0.00573	CcSEcCtD
Nortriptyline—ORM1—liver—colon cancer	0.00147	0.00868	CbGeAlD
Nortriptyline—HTR2A—embryo—colon cancer	0.00143	0.00846	CbGeAlD
Nortriptyline—Pancytopenia—Vincristine—colon cancer	0.00142	0.00552	CcSEcCtD
Nortriptyline—Sweating increased—Irinotecan—colon cancer	0.00142	0.00552	CcSEcCtD
Nortriptyline—Petechiae—Methotrexate—colon cancer	0.00141	0.00547	CcSEcCtD
Nortriptyline—HRH1—epithelium—colon cancer	0.0014	0.00826	CbGeAlD
Nortriptyline—CYP2C19—digestive system—colon cancer	0.00139	0.00822	CbGeAlD
Nortriptyline—ADRA1A—lymphoid tissue—colon cancer	0.00139	0.00822	CbGeAlD
Nortriptyline—CYP1A2—renal system—colon cancer	0.00138	0.00819	CbGeAlD
Nortriptyline—Eosinophilia—Fluorouracil—colon cancer	0.00138	0.00537	CcSEcCtD
Nortriptyline—Erectile dysfunction—Vincristine—colon cancer	0.00138	0.00535	CcSEcCtD
Nortriptyline—Weight decreased—Vincristine—colon cancer	0.00135	0.00526	CcSEcCtD
Nortriptyline—HRH1—smooth muscle tissue—colon cancer	0.00135	0.00796	CbGeAlD
Nortriptyline—CYP3A5—renal system—colon cancer	0.00133	0.0079	CbGeAlD
Nortriptyline—Pancytopenia—Fluorouracil—colon cancer	0.00132	0.00515	CcSEcCtD
Nortriptyline—Weight decreased—Irinotecan—colon cancer	0.00132	0.00512	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Vincristine—colon cancer	0.00131	0.00511	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Vincristine—colon cancer	0.00131	0.00508	CcSEcCtD
Nortriptyline—Myocardial infarction—Vincristine—colon cancer	0.00131	0.00508	CcSEcCtD
Nortriptyline—Stomatitis—Vincristine—colon cancer	0.0013	0.00505	CcSEcCtD
Nortriptyline—PTGS1—epithelium—colon cancer	0.00129	0.00765	CbGeAlD
Nortriptyline—Hepatic function abnormal—Capecitabine—colon cancer	0.00129	0.00502	CcSEcCtD
Nortriptyline—ALB—liver—colon cancer	0.00129	0.00761	CbGeAlD
Nortriptyline—Acute coronary syndrome—Irinotecan—colon cancer	0.00128	0.00498	CcSEcCtD
Nortriptyline—Sweating—Vincristine—colon cancer	0.00128	0.00497	CcSEcCtD
Nortriptyline—Myocardial infarction—Irinotecan—colon cancer	0.00127	0.00495	CcSEcCtD
Nortriptyline—Stomatitis—Irinotecan—colon cancer	0.00127	0.00492	CcSEcCtD
Nortriptyline—Jaundice—Irinotecan—colon cancer	0.00127	0.00492	CcSEcCtD
Nortriptyline—Vascular purpura—Capecitabine—colon cancer	0.00126	0.0049	CcSEcCtD
Nortriptyline—Eye pain—Capecitabine—colon cancer	0.00125	0.00486	CcSEcCtD
Nortriptyline—PTGS1—smooth muscle tissue—colon cancer	0.00125	0.00737	CbGeAlD
Nortriptyline—CYP2E1—renal system—colon cancer	0.00125	0.00737	CbGeAlD
Nortriptyline—Sweating—Irinotecan—colon cancer	0.00124	0.00484	CcSEcCtD
Nortriptyline—CYP2C19—vagina—colon cancer	0.00123	0.00726	CbGeAlD
Nortriptyline—Acute coronary syndrome—Fluorouracil—colon cancer	0.00123	0.00477	CcSEcCtD
Nortriptyline—Myocardial infarction—Fluorouracil—colon cancer	0.00122	0.00474	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Fluorouracil—colon cancer	0.00122	0.00474	CcSEcCtD
Nortriptyline—Libido decreased—Capecitabine—colon cancer	0.00122	0.00473	CcSEcCtD
Nortriptyline—Stomatitis—Fluorouracil—colon cancer	0.00121	0.00471	CcSEcCtD
Nortriptyline—Hot flush—Capecitabine—colon cancer	0.00121	0.00469	CcSEcCtD
Nortriptyline—PTGS1—renal system—colon cancer	0.0012	0.00709	CbGeAlD
Nortriptyline—Menopausal symptoms—Capecitabine—colon cancer	0.0012	0.00465	CcSEcCtD
Nortriptyline—Hypoaesthesia—Vincristine—colon cancer	0.00119	0.00463	CcSEcCtD
Nortriptyline—Hallucination—Vincristine—colon cancer	0.00119	0.00463	CcSEcCtD
Nortriptyline—Purpura—Capecitabine—colon cancer	0.00117	0.00455	CcSEcCtD
Nortriptyline—HTR2A—epithelium—colon cancer	0.00117	0.0069	CbGeAlD
Nortriptyline—Agranulocytosis—Fluorouracil—colon cancer	0.00116	0.00451	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Capecitabine—colon cancer	0.00115	0.00447	CcSEcCtD
Nortriptyline—CYP1A2—digestive system—colon cancer	0.00114	0.00672	CbGeAlD
Nortriptyline—ORM1—lymph node—colon cancer	0.00112	0.00665	CbGeAlD
Nortriptyline—HTR2A—smooth muscle tissue—colon cancer	0.00112	0.00665	CbGeAlD
Nortriptyline—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00112	0.00435	CcSEcCtD
Nortriptyline—Hypoaesthesia—Fluorouracil—colon cancer	0.00111	0.00432	CcSEcCtD
Nortriptyline—CYP3A5—digestive system—colon cancer	0.00109	0.00648	CbGeAlD
Nortriptyline—Aplastic anaemia—Methotrexate—colon cancer	0.00109	0.00422	CcSEcCtD
Nortriptyline—HTR2A—renal system—colon cancer	0.00108	0.0064	CbGeAlD
Nortriptyline—Flushing—Irinotecan—colon cancer	0.00108	0.00421	CcSEcCtD
Nortriptyline—CYP2C9—digestive system—colon cancer	0.00108	0.00637	CbGeAlD
Nortriptyline—Irritability—Capecitabine—colon cancer	0.00108	0.00418	CcSEcCtD
Nortriptyline—Urinary retention—Capecitabine—colon cancer	0.00107	0.00417	CcSEcCtD
Nortriptyline—HRH1—digestive system—colon cancer	0.00106	0.00629	CbGeAlD
Nortriptyline—Ataxia—Capecitabine—colon cancer	0.00106	0.00412	CcSEcCtD
Nortriptyline—Alopecia—Vincristine—colon cancer	0.00106	0.00411	CcSEcCtD
Nortriptyline—Arrhythmia—Irinotecan—colon cancer	0.00104	0.00405	CcSEcCtD
Nortriptyline—CYP2C19—liver—colon cancer	0.00104	0.00613	CbGeAlD
Nortriptyline—Gynaecomastia—Methotrexate—colon cancer	0.00103	0.00402	CcSEcCtD
Nortriptyline—CYP2E1—lymphoid tissue—colon cancer	0.00103	0.00612	CbGeAlD
Nortriptyline—Alopecia—Irinotecan—colon cancer	0.00103	0.004	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Capecitabine—colon cancer	0.00103	0.004	CcSEcCtD
Nortriptyline—ADRA1A—liver—colon cancer	0.00102	0.00605	CbGeAlD
Nortriptyline—CYP2E1—digestive system—colon cancer	0.00102	0.00604	CbGeAlD
Nortriptyline—Protriptyline—ABCB1—colon cancer	0.00102	0.212	CrCbGaD
Nortriptyline—CYP3A4—renal system—colon cancer	0.001	0.00593	CbGeAlD
Nortriptyline—Arrhythmia—Fluorouracil—colon cancer	0.000997	0.00388	CcSEcCtD
Nortriptyline—Alopecia—Fluorouracil—colon cancer	0.000986	0.00384	CcSEcCtD
Nortriptyline—ALB—lymph node—colon cancer	0.000986	0.00583	CbGeAlD
Nortriptyline—CYP2D6—renal system—colon cancer	0.000986	0.00583	CbGeAlD
Nortriptyline—PTGS1—digestive system—colon cancer	0.000984	0.00582	CbGeAlD
Nortriptyline—CYP3A5—vagina—colon cancer	0.000967	0.00572	CbGeAlD
Nortriptyline—Agitation—Vincristine—colon cancer	0.000957	0.00372	CcSEcCtD
Nortriptyline—Sweating increased—Capecitabine—colon cancer	0.000949	0.00369	CcSEcCtD
Nortriptyline—Ill-defined disorder—Irinotecan—colon cancer	0.000941	0.00366	CcSEcCtD
Nortriptyline—HRH1—vagina—colon cancer	0.000938	0.00555	CbGeAlD
Nortriptyline—Leukopenia—Vincristine—colon cancer	0.000933	0.00363	CcSEcCtD
Nortriptyline—Pancytopenia—Capecitabine—colon cancer	0.000926	0.0036	CcSEcCtD
Nortriptyline—Vision blurred—Fluorouracil—colon cancer	0.000916	0.00356	CcSEcCtD
Nortriptyline—Malaise—Irinotecan—colon cancer	0.000915	0.00356	CcSEcCtD
Nortriptyline—Syncope—Irinotecan—colon cancer	0.00091	0.00354	CcSEcCtD
Nortriptyline—Leukopenia—Irinotecan—colon cancer	0.000908	0.00353	CcSEcCtD
Nortriptyline—Convulsion—Vincristine—colon cancer	0.000903	0.00351	CcSEcCtD
Nortriptyline—Hypertension—Vincristine—colon cancer	0.000899	0.0035	CcSEcCtD
Nortriptyline—Loss of consciousness—Irinotecan—colon cancer	0.000892	0.00347	CcSEcCtD
Nortriptyline—HTR2A—digestive system—colon cancer	0.000888	0.00525	CbGeAlD
Nortriptyline—Weight increased—Capecitabine—colon cancer	0.000887	0.00345	CcSEcCtD
Nortriptyline—Weight decreased—Capecitabine—colon cancer	0.000882	0.00343	CcSEcCtD
Nortriptyline—Hypertension—Irinotecan—colon cancer	0.000876	0.00341	CcSEcCtD
Nortriptyline—Leukopenia—Fluorouracil—colon cancer	0.00087	0.00338	CcSEcCtD
Nortriptyline—PTGS1—vagina—colon cancer	0.000869	0.00514	CbGeAlD
Nortriptyline—Acute coronary syndrome—Capecitabine—colon cancer	0.000857	0.00333	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Methotrexate—colon cancer	0.000857	0.00333	CcSEcCtD
Nortriptyline—Discomfort—Irinotecan—colon cancer	0.000853	0.00332	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Capecitabine—colon cancer	0.000852	0.00331	CcSEcCtD
Nortriptyline—Myocardial infarction—Capecitabine—colon cancer	0.000852	0.00331	CcSEcCtD
Nortriptyline—Oedema—Vincristine—colon cancer	0.00085	0.00331	CcSEcCtD
Nortriptyline—Jaundice—Capecitabine—colon cancer	0.000847	0.00329	CcSEcCtD
Nortriptyline—Stomatitis—Capecitabine—colon cancer	0.000847	0.00329	CcSEcCtD
Nortriptyline—CYP1A2—liver—colon cancer	0.000846	0.005	CbGeAlD
Nortriptyline—SLC6A2—lymph node—colon cancer	0.000844	0.00499	CbGeAlD
Nortriptyline—Convulsion—Fluorouracil—colon cancer	0.000842	0.00327	CcSEcCtD
Nortriptyline—Confusional state—Irinotecan—colon cancer	0.000835	0.00325	CcSEcCtD
Nortriptyline—Thrombocytopenia—Vincristine—colon cancer	0.000833	0.00324	CcSEcCtD
Nortriptyline—Oedema—Irinotecan—colon cancer	0.000828	0.00322	CcSEcCtD
Nortriptyline—Hyperhidrosis—Vincristine—colon cancer	0.000822	0.0032	CcSEcCtD
Nortriptyline—CYP3A4—digestive system—colon cancer	0.000822	0.00486	CbGeAlD
Nortriptyline—Discomfort—Fluorouracil—colon cancer	0.000817	0.00318	CcSEcCtD
Nortriptyline—CYP3A5—liver—colon cancer	0.000816	0.00483	CbGeAlD
Nortriptyline—Shock—Irinotecan—colon cancer	0.000815	0.00317	CcSEcCtD
Nortriptyline—Agranulocytosis—Capecitabine—colon cancer	0.000811	0.00315	CcSEcCtD
Nortriptyline—Thrombocytopenia—Irinotecan—colon cancer	0.000811	0.00315	CcSEcCtD
Nortriptyline—Anorexia—Vincristine—colon cancer	0.00081	0.00315	CcSEcCtD
Nortriptyline—CYP2D6—digestive system—colon cancer	0.000809	0.00478	CbGeAlD
Nortriptyline—CYP2C9—liver—colon cancer	0.000803	0.00475	CbGeAlD
Nortriptyline—Irritability—Methotrexate—colon cancer	0.000801	0.00312	CcSEcCtD
Nortriptyline—Hyperhidrosis—Irinotecan—colon cancer	0.000801	0.00311	CcSEcCtD
Nortriptyline—Confusional state—Fluorouracil—colon cancer	0.0008	0.00311	CcSEcCtD
Nortriptyline—Hypotension—Vincristine—colon cancer	0.000795	0.00309	CcSEcCtD
Nortriptyline—Oedema—Fluorouracil—colon cancer	0.000793	0.00308	CcSEcCtD
Nortriptyline—Anorexia—Irinotecan—colon cancer	0.000789	0.00307	CcSEcCtD
Nortriptyline—Ataxia—Methotrexate—colon cancer	0.000789	0.00307	CcSEcCtD
Nortriptyline—HTR2A—vagina—colon cancer	0.000784	0.00464	CbGeAlD
Nortriptyline—Hepatitis—Capecitabine—colon cancer	0.00078	0.00303	CcSEcCtD
Nortriptyline—Thrombocytopenia—Fluorouracil—colon cancer	0.000777	0.00302	CcSEcCtD
Nortriptyline—Hypoaesthesia—Capecitabine—colon cancer	0.000776	0.00302	CcSEcCtD
Nortriptyline—Tachycardia—Fluorouracil—colon cancer	0.000774	0.00301	CcSEcCtD
Nortriptyline—Hypotension—Irinotecan—colon cancer	0.000774	0.00301	CcSEcCtD
Nortriptyline—Insomnia—Vincristine—colon cancer	0.000769	0.00299	CcSEcCtD
Nortriptyline—Oedema peripheral—Capecitabine—colon cancer	0.000768	0.00299	CcSEcCtD
Nortriptyline—Paraesthesia—Vincristine—colon cancer	0.000764	0.00297	CcSEcCtD
Nortriptyline—CYP2E1—liver—colon cancer	0.000761	0.0045	CbGeAlD
Nortriptyline—Epinastine—ABCB1—colon cancer	0.000756	0.157	CrCbGaD
Nortriptyline—Anorexia—Fluorouracil—colon cancer	0.000756	0.00294	CcSEcCtD
Nortriptyline—Insomnia—Irinotecan—colon cancer	0.000749	0.00291	CcSEcCtD
Nortriptyline—Paraesthesia—Irinotecan—colon cancer	0.000744	0.00289	CcSEcCtD
Nortriptyline—Hypotension—Fluorouracil—colon cancer	0.000741	0.00288	CcSEcCtD
Nortriptyline—Decreased appetite—Vincristine—colon cancer	0.000739	0.00287	CcSEcCtD
Nortriptyline—Somnolence—Irinotecan—colon cancer	0.000736	0.00286	CcSEcCtD
Nortriptyline—Fatigue—Vincristine—colon cancer	0.000733	0.00285	CcSEcCtD
Nortriptyline—Eye disorder—Capecitabine—colon cancer	0.000729	0.00283	CcSEcCtD
Nortriptyline—Dyspepsia—Irinotecan—colon cancer	0.000729	0.00283	CcSEcCtD
Nortriptyline—Tinnitus—Capecitabine—colon cancer	0.000727	0.00283	CcSEcCtD
Nortriptyline—Constipation—Vincristine—colon cancer	0.000727	0.00283	CcSEcCtD
Nortriptyline—Flushing—Capecitabine—colon cancer	0.000724	0.00281	CcSEcCtD
Nortriptyline—Decreased appetite—Irinotecan—colon cancer	0.00072	0.0028	CcSEcCtD
Nortriptyline—Eosinophilia—Methotrexate—colon cancer	0.000718	0.00279	CcSEcCtD
Nortriptyline—Insomnia—Fluorouracil—colon cancer	0.000717	0.00279	CcSEcCtD
Nortriptyline—Fatigue—Irinotecan—colon cancer	0.000714	0.00278	CcSEcCtD
Nortriptyline—Paraesthesia—Fluorouracil—colon cancer	0.000712	0.00277	CcSEcCtD
Nortriptyline—Constipation—Irinotecan—colon cancer	0.000708	0.00275	CcSEcCtD
Nortriptyline—Somnolence—Fluorouracil—colon cancer	0.000705	0.00274	CcSEcCtD
Nortriptyline—Dyspepsia—Fluorouracil—colon cancer	0.000698	0.00271	CcSEcCtD
Nortriptyline—Arrhythmia—Capecitabine—colon cancer	0.000697	0.00271	CcSEcCtD
Nortriptyline—Decreased appetite—Fluorouracil—colon cancer	0.000689	0.00268	CcSEcCtD
Nortriptyline—Alopecia—Capecitabine—colon cancer	0.000689	0.00268	CcSEcCtD
Nortriptyline—Pancytopenia—Methotrexate—colon cancer	0.000689	0.00268	CcSEcCtD
Nortriptyline—Feeling abnormal—Irinotecan—colon cancer	0.000682	0.00265	CcSEcCtD
Nortriptyline—Body temperature increased—Vincristine—colon cancer	0.000672	0.00261	CcSEcCtD
Nortriptyline—Abdominal pain—Vincristine—colon cancer	0.000672	0.00261	CcSEcCtD
Nortriptyline—Erectile dysfunction—Methotrexate—colon cancer	0.000668	0.0026	CcSEcCtD
Nortriptyline—Dysgeusia—Capecitabine—colon cancer	0.000665	0.00259	CcSEcCtD
Nortriptyline—HTR2A—liver—colon cancer	0.000661	0.00391	CbGeAlD
Nortriptyline—Abdominal pain—Irinotecan—colon cancer	0.000655	0.00255	CcSEcCtD
Nortriptyline—Body temperature increased—Irinotecan—colon cancer	0.000655	0.00255	CcSEcCtD
Nortriptyline—Feeling abnormal—Fluorouracil—colon cancer	0.000654	0.00254	CcSEcCtD
Nortriptyline—Maprotiline—ABCB1—colon cancer	0.000651	0.135	CrCbGaD
Nortriptyline—Drowsiness—Methotrexate—colon cancer	0.000647	0.00252	CcSEcCtD
Nortriptyline—Vision blurred—Capecitabine—colon cancer	0.00064	0.00249	CcSEcCtD
Nortriptyline—Tremor—Capecitabine—colon cancer	0.000636	0.00247	CcSEcCtD
Nortriptyline—Stomatitis—Methotrexate—colon cancer	0.000631	0.00245	CcSEcCtD
Nortriptyline—Ill-defined disorder—Capecitabine—colon cancer	0.00063	0.00245	CcSEcCtD
Nortriptyline—Urticaria—Fluorouracil—colon cancer	0.00063	0.00245	CcSEcCtD
Nortriptyline—Body temperature increased—Fluorouracil—colon cancer	0.000627	0.00244	CcSEcCtD
Nortriptyline—Hypersensitivity—Vincristine—colon cancer	0.000626	0.00244	CcSEcCtD
Nortriptyline—Sweating—Methotrexate—colon cancer	0.00062	0.00241	CcSEcCtD
Nortriptyline—Malaise—Capecitabine—colon cancer	0.000612	0.00238	CcSEcCtD
Nortriptyline—CYP3A4—liver—colon cancer	0.000612	0.00362	CbGeAlD
Nortriptyline—Hypersensitivity—Irinotecan—colon cancer	0.00061	0.00237	CcSEcCtD
Nortriptyline—Asthenia—Vincristine—colon cancer	0.00061	0.00237	CcSEcCtD
Nortriptyline—Syncope—Capecitabine—colon cancer	0.000609	0.00237	CcSEcCtD
Nortriptyline—Leukopenia—Capecitabine—colon cancer	0.000608	0.00236	CcSEcCtD
Nortriptyline—HRH1—lymph node—colon cancer	0.000607	0.00359	CbGeAlD
Nortriptyline—Agranulocytosis—Methotrexate—colon cancer	0.000604	0.00235	CcSEcCtD
Nortriptyline—CYP2D6—liver—colon cancer	0.000602	0.00356	CbGeAlD
Nortriptyline—Palpitations—Capecitabine—colon cancer	0.0006	0.00233	CcSEcCtD
Nortriptyline—Loss of consciousness—Capecitabine—colon cancer	0.000597	0.00232	CcSEcCtD
Nortriptyline—Asthenia—Irinotecan—colon cancer	0.000594	0.00231	CcSEcCtD
Nortriptyline—Hypertension—Capecitabine—colon cancer	0.000586	0.00228	CcSEcCtD
Nortriptyline—Hypersensitivity—Fluorouracil—colon cancer	0.000584	0.00227	CcSEcCtD
Nortriptyline—Diarrhoea—Vincristine—colon cancer	0.000582	0.00226	CcSEcCtD
Nortriptyline—Hepatitis—Methotrexate—colon cancer	0.000581	0.00226	CcSEcCtD
Nortriptyline—Anxiety—Capecitabine—colon cancer	0.000576	0.00224	CcSEcCtD
Nortriptyline—Discomfort—Capecitabine—colon cancer	0.000571	0.00222	CcSEcCtD
Nortriptyline—Diarrhoea—Irinotecan—colon cancer	0.000567	0.0022	CcSEcCtD
Nortriptyline—Dry mouth—Capecitabine—colon cancer	0.000565	0.0022	CcSEcCtD
Nortriptyline—Dizziness—Vincristine—colon cancer	0.000562	0.00219	CcSEcCtD
Nortriptyline—PTGS1—lymph node—colon cancer	0.000562	0.00332	CbGeAlD
Nortriptyline—Pruritus—Fluorouracil—colon cancer	0.000561	0.00218	CcSEcCtD
Nortriptyline—Confusional state—Capecitabine—colon cancer	0.000559	0.00217	CcSEcCtD
Nortriptyline—Oedema—Capecitabine—colon cancer	0.000554	0.00215	CcSEcCtD
Nortriptyline—Dizziness—Irinotecan—colon cancer	0.000548	0.00213	CcSEcCtD
Nortriptyline—Shock—Capecitabine—colon cancer	0.000545	0.00212	CcSEcCtD
Nortriptyline—Eye disorder—Methotrexate—colon cancer	0.000543	0.00211	CcSEcCtD
Nortriptyline—Diarrhoea—Fluorouracil—colon cancer	0.000543	0.00211	CcSEcCtD
Nortriptyline—Thrombocytopenia—Capecitabine—colon cancer	0.000543	0.00211	CcSEcCtD
Nortriptyline—Tinnitus—Methotrexate—colon cancer	0.000541	0.00211	CcSEcCtD
Nortriptyline—Tachycardia—Capecitabine—colon cancer	0.000541	0.0021	CcSEcCtD
Nortriptyline—Vomiting—Vincristine—colon cancer	0.000541	0.0021	CcSEcCtD
Nortriptyline—Rash—Vincristine—colon cancer	0.000536	0.00208	CcSEcCtD
Nortriptyline—Hyperhidrosis—Capecitabine—colon cancer	0.000536	0.00208	CcSEcCtD
Nortriptyline—Dermatitis—Vincristine—colon cancer	0.000536	0.00208	CcSEcCtD
Nortriptyline—Headache—Vincristine—colon cancer	0.000533	0.00207	CcSEcCtD
Nortriptyline—Anorexia—Capecitabine—colon cancer	0.000528	0.00205	CcSEcCtD
Nortriptyline—Vomiting—Irinotecan—colon cancer	0.000526	0.00205	CcSEcCtD
Nortriptyline—Dizziness—Fluorouracil—colon cancer	0.000524	0.00204	CcSEcCtD
Nortriptyline—Rash—Irinotecan—colon cancer	0.000522	0.00203	CcSEcCtD
Nortriptyline—Dermatitis—Irinotecan—colon cancer	0.000522	0.00203	CcSEcCtD
Nortriptyline—Headache—Irinotecan—colon cancer	0.000519	0.00202	CcSEcCtD
Nortriptyline—Hypotension—Capecitabine—colon cancer	0.000518	0.00201	CcSEcCtD
Nortriptyline—Alopecia—Methotrexate—colon cancer	0.000513	0.002	CcSEcCtD
Nortriptyline—Nausea—Vincristine—colon cancer	0.000505	0.00196	CcSEcCtD
Nortriptyline—Vomiting—Fluorouracil—colon cancer	0.000504	0.00196	CcSEcCtD
Nortriptyline—Insomnia—Capecitabine—colon cancer	0.000501	0.00195	CcSEcCtD
Nortriptyline—Rash—Fluorouracil—colon cancer	0.0005	0.00194	CcSEcCtD
Nortriptyline—Dermatitis—Fluorouracil—colon cancer	0.0005	0.00194	CcSEcCtD
Nortriptyline—Paraesthesia—Capecitabine—colon cancer	0.000498	0.00194	CcSEcCtD
Nortriptyline—Headache—Fluorouracil—colon cancer	0.000497	0.00193	CcSEcCtD
Nortriptyline—Dysgeusia—Methotrexate—colon cancer	0.000495	0.00192	CcSEcCtD
Nortriptyline—Nausea—Irinotecan—colon cancer	0.000492	0.00191	CcSEcCtD
Nortriptyline—Dyspepsia—Capecitabine—colon cancer	0.000488	0.0019	CcSEcCtD
Nortriptyline—Decreased appetite—Capecitabine—colon cancer	0.000482	0.00187	CcSEcCtD
Nortriptyline—Fatigue—Capecitabine—colon cancer	0.000478	0.00186	CcSEcCtD
Nortriptyline—Vision blurred—Methotrexate—colon cancer	0.000476	0.00185	CcSEcCtD
Nortriptyline—Constipation—Capecitabine—colon cancer	0.000474	0.00184	CcSEcCtD
Nortriptyline—Nausea—Fluorouracil—colon cancer	0.000471	0.00183	CcSEcCtD
Nortriptyline—Ill-defined disorder—Methotrexate—colon cancer	0.000469	0.00182	CcSEcCtD
Nortriptyline—Feeling abnormal—Capecitabine—colon cancer	0.000457	0.00178	CcSEcCtD
Nortriptyline—Malaise—Methotrexate—colon cancer	0.000456	0.00177	CcSEcCtD
Nortriptyline—Leukopenia—Methotrexate—colon cancer	0.000452	0.00176	CcSEcCtD
Nortriptyline—Urticaria—Capecitabine—colon cancer	0.00044	0.00171	CcSEcCtD
Nortriptyline—Abdominal pain—Capecitabine—colon cancer	0.000438	0.0017	CcSEcCtD
Nortriptyline—Body temperature increased—Capecitabine—colon cancer	0.000438	0.0017	CcSEcCtD
Nortriptyline—Convulsion—Methotrexate—colon cancer	0.000438	0.0017	CcSEcCtD
Nortriptyline—Discomfort—Methotrexate—colon cancer	0.000425	0.00165	CcSEcCtD
Nortriptyline—Confusional state—Methotrexate—colon cancer	0.000416	0.00162	CcSEcCtD
Nortriptyline—Hypersensitivity—Capecitabine—colon cancer	0.000408	0.00159	CcSEcCtD
Nortriptyline—Thrombocytopenia—Methotrexate—colon cancer	0.000404	0.00157	CcSEcCtD
Nortriptyline—Clomipramine—ABCB1—colon cancer	0.0004	0.0831	CrCbGaD
Nortriptyline—Hyperhidrosis—Methotrexate—colon cancer	0.000399	0.00155	CcSEcCtD
Nortriptyline—Chlorprothixene—ABCB1—colon cancer	0.000399	0.0828	CrCbGaD
Nortriptyline—Asthenia—Capecitabine—colon cancer	0.000398	0.00155	CcSEcCtD
Nortriptyline—Anorexia—Methotrexate—colon cancer	0.000393	0.00153	CcSEcCtD
Nortriptyline—Pruritus—Capecitabine—colon cancer	0.000392	0.00152	CcSEcCtD
Nortriptyline—Hypotension—Methotrexate—colon cancer	0.000386	0.0015	CcSEcCtD
Nortriptyline—Diarrhoea—Capecitabine—colon cancer	0.000379	0.00147	CcSEcCtD
Nortriptyline—Insomnia—Methotrexate—colon cancer	0.000373	0.00145	CcSEcCtD
Nortriptyline—Paraesthesia—Methotrexate—colon cancer	0.00037	0.00144	CcSEcCtD
Nortriptyline—Trimipramine—ABCB1—colon cancer	0.000368	0.0765	CrCbGaD
Nortriptyline—Somnolence—Methotrexate—colon cancer	0.000367	0.00143	CcSEcCtD
Nortriptyline—Dizziness—Capecitabine—colon cancer	0.000366	0.00142	CcSEcCtD
Nortriptyline—Dyspepsia—Methotrexate—colon cancer	0.000363	0.00141	CcSEcCtD
Nortriptyline—Decreased appetite—Methotrexate—colon cancer	0.000359	0.00139	CcSEcCtD
Nortriptyline—Fatigue—Methotrexate—colon cancer	0.000356	0.00138	CcSEcCtD
Nortriptyline—Vomiting—Capecitabine—colon cancer	0.000352	0.00137	CcSEcCtD
Nortriptyline—Doxepin—ABCB1—colon cancer	0.000351	0.0729	CrCbGaD
Nortriptyline—Rash—Capecitabine—colon cancer	0.000349	0.00136	CcSEcCtD
Nortriptyline—Dermatitis—Capecitabine—colon cancer	0.000349	0.00136	CcSEcCtD
Nortriptyline—Headache—Capecitabine—colon cancer	0.000347	0.00135	CcSEcCtD
Nortriptyline—Feeling abnormal—Methotrexate—colon cancer	0.00034	0.00132	CcSEcCtD
Nortriptyline—Nausea—Capecitabine—colon cancer	0.000329	0.00128	CcSEcCtD
Nortriptyline—Urticaria—Methotrexate—colon cancer	0.000328	0.00127	CcSEcCtD
Nortriptyline—Abdominal pain—Methotrexate—colon cancer	0.000326	0.00127	CcSEcCtD
Nortriptyline—Body temperature increased—Methotrexate—colon cancer	0.000326	0.00127	CcSEcCtD
Nortriptyline—Desipramine—ABCB1—colon cancer	0.000322	0.0669	CrCbGaD
Nortriptyline—Hypersensitivity—Methotrexate—colon cancer	0.000304	0.00118	CcSEcCtD
Nortriptyline—Asthenia—Methotrexate—colon cancer	0.000296	0.00115	CcSEcCtD
Nortriptyline—Pruritus—Methotrexate—colon cancer	0.000292	0.00113	CcSEcCtD
Nortriptyline—Diarrhoea—Methotrexate—colon cancer	0.000282	0.0011	CcSEcCtD
Nortriptyline—Imipramine—ABCB1—colon cancer	0.000273	0.0567	CrCbGaD
Nortriptyline—Dizziness—Methotrexate—colon cancer	0.000273	0.00106	CcSEcCtD
Nortriptyline—Amitriptyline—ABCB1—colon cancer	0.000271	0.0564	CrCbGaD
Nortriptyline—Vomiting—Methotrexate—colon cancer	0.000262	0.00102	CcSEcCtD
Nortriptyline—Rash—Methotrexate—colon cancer	0.00026	0.00101	CcSEcCtD
Nortriptyline—Dermatitis—Methotrexate—colon cancer	0.00026	0.00101	CcSEcCtD
Nortriptyline—Headache—Methotrexate—colon cancer	0.000258	0.001	CcSEcCtD
Nortriptyline—Nausea—Methotrexate—colon cancer	0.000245	0.000953	CcSEcCtD
